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Human GBP1 is a microbe-specific gatekeeper of
macrophage apoptosis and pyroptosis
Daniel Fisch1,2 , Hironori Bando3,4, Barbara Clough1, Veit Hornung5, Masahiro Yamamoto3,4,
Avinash R Shenoy2,6,* & Eva-Maria Frickel1,**
Abstract
The guanylate binding protein (GBP) family of interferon-inducible
GTPases promotes antimicrobial immunity and cell death. During
bacterial infection, multiple mouse Gbps, human GBP2, and GBP5
support the activation of caspase-1-containing inflammasome
complexes or caspase-4 which trigger pyroptosis. Whether GBPs
regulate other forms of cell death is not known. The apicomplexan
parasite Toxoplasma gondii causes macrophage death through
unidentified mechanisms. Here we report that Toxoplasma-induced
death of human macrophages requires GBP1 and its ability to
target Toxoplasma parasitophorous vacuoles through its GTPase
activity and prenylation. Mechanistically, GBP1 promoted Toxo-
plasma detection by AIM2, which induced GSDMD-independent,
ASC-, and caspase-8-dependent apoptosis. Identical molecular
determinants targeted GBP1 to Salmonella-containing vacuoles.
GBP1 facilitated caspase-4 recruitment to Salmonella leading to its
enhanced activation and pyroptosis. Notably, GBP1 could be
bypassed by the delivery of Toxoplasma DNA or bacterial LPS into
the cytosol, pointing to its role in liberating microbial molecules.
GBP1 thus acts as a gatekeeper of cell death pathways, which
respond specifically to infecting microbes. Our findings expand the
immune roles of human GBPs in regulating not only pyroptosis,
but also apoptosis.
Keywords apoptosis; caspases; pyroptosis; Salmonella Typhimurium;
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Introduction
Interferon gamma (IFNc) plays a pivotal role in antimicrobial
defense, and loss-of-function mutations in IFNc-receptor signaling
in the human and mouse result in severe susceptibility to infections,
including by bacteria and microbial parasites (Altare et al, 1998;
Levin & Newport, 1999; Janssen et al, 2002). IFNc-priming of
macrophages, which is crucial in restricting pathogen growth and
controlling infection, upregulates key antimicrobial molecules that
mediate cell-intrinsic control of pathogens (Mosser & Edwards,
2008; MacMicking, 2012; Randow et al, 2013) and enhances pyrop-
totic cell death (Shenoy et al, 2012; Meunier et al, 2014; Pilla et al,
2014; Finethy et al, 2015; Santos et al, 2018).
Among the most abundant IFNc-induced immune proteins are
the guanylate binding proteins (GBPs), a family of large GTPases
(65–72 kDa) which restrict bacterial replication and promote
inflammasome signaling (Kim et al, 2011; Shenoy et al, 2012;
Meunier & Broz, 2016; Pilla-Moffett et al, 2016; Ngo & Man, 2017).
The human genome harbors 7 GBP genes, among which GBP1-5 are
the most ubiquitously expressed members and GBP6 and 7 are only
found in epithelial cells lining mucosal surfaces of the lung and
intestines (Uhlen et al, 2015). In contrast, the mouse genome
encodes 11 Gbps at two separate chromosomal loci (chr 3 and chr
5), whose protective roles have been revealed through studies on
mice lacking Gbp1, Gbp2, Gbp5, or all Gbps on Chr3 (Degrandi et al,
2007, 2013; Kim et al, 2011; Shenoy et al, 2012; Yamamoto et al,
2012; Lindenberg et al, 2017). Mouse mGbp1, 2, 3, 5, 6, 7, 9, and 10
can be recruited to vacuoles of bacteria such as Salmonella, Listeria,
Francisella, Mycobacterium, Chlamydia, and Legionella (Kim et al,
2011; Degrandi et al, 2013; Haldar et al, 2014; Meunier et al, 2014,
2015; Feeley et al, 2017; Finethy et al, 2017; Lindenberg et al, 2017)
or parasites such as Toxoplasma gondii (Tg; Degrandi et al, 2007;
Virreira Winter et al, 2011; Kravets et al, 2012, 2016; Selleck et al,
2013; Haldar et al, 2015). Human GBP1, 2, and 5 have a C-terminal
CaaX motif that can be isoprenylated to facilitate membrane recruit-
ment (Britzen-Laurent et al, 2010). Additionally, GTPase activity
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and GBP oligomerization, which depend on critical amino acids,
have been studied biochemically before and need to be character-
ized in infected human macrophages (Daumke & Praefcke, 2016;
Shydlovskyi et al, 2017). Murine Gbps facilitate the release of
microbial ligands, such as LPS or DNA, and promote pyroptosis
(Meunier et al, 2014, 2015; Pilla et al, 2014; Haldar et al, 2015; Man
et al, 2015; Feeley et al, 2017; Finethy et al, 2017; Piro et al, 2017).
However, mGbp2 can promote LPS detection by caspase-11 inde-
pendently of bacterial lysis (Pilla et al, 2014). Similarly, GBP5/
mGbp5 has been implicated in the regulation of NLRP3 activation
by pathogenic bacteria and soluble inflammasome priming agents
(Shenoy et al, 2012), and caspase-11-driven responses to LPS-
containing outer membrane vesicles (OMVs; Santos et al, 2018).
Strikingly, how human macrophages are equipped to defend them-
selves against bacterial or parasitic pathogen infections, via the
breadth of roles the human GBPs play, remains unstudied. Recent
studies have shown cell type-specific roles of human GBPs which
underscore the need for defining the roles of GBPs in macrophages
during infection (Al-zeer et al, 2013; Johnston et al, 2016; Qin et al,
2017).
Inflammasomes are multimolecular complexes that activate
caspase-1 in response to microbial or danger/damage-associated
signals (Broz & Dixit, 2016). In specific contexts, such as infection
by Gram-negative bacteria, caspase-4 and caspase-8 can regulate the
assembly of inflammasomes and caspase-1 activation (Kayagaki
et al, 2011; Rathinam Vijay et al, 2012; Man et al, 2013; Gurung
et al, 2014; Antonopoulos et al, 2015; Vigano` et al, 2015). The
release of Francisella DNA by mGbp2 and mGbp5 is detected by the
DNA-binding protein AIM2, which activates caspase-1 in mouse
macrophages through the adaptor protein ASC (Man et al, 2015;
Meunier et al, 2015). However, recent studies in primary human
myeloid cells have suggested that cytosolic DNA stimulates a cGAS-
STING-dependent pathway that results in secondary NLRP3 activa-
tion, whereas AIM2 was dispensable (Fernandes-Alnemri et al,
2009; Gaidt et al, 2017).
IFNc-signaling deficiency in mice results in extreme susceptibility
to infection by the eukaryotic pathogen Tg and the Gram-negative
bacterial pathogen Salmonella enterica Typhimurium (STm), among
others (Jouanguy et al, 1999; Hunter & Sibley, 2012). Tg infection
causes chronic disease that can lead to death in the immunocompro-
mised and fetal abnormalities in cases of the mother acquiring a
primary infection during pregnancy (Pappas et al, 2009; Torgerson
& Mastroiacovo, 2013). STm is a broad host-range pathogen that
causes gastrointestinal disease in humans (Coburn et al, 2007).
Human IFNc deficiency also results in sensitivity to environmental
salmonellae (Jouanguy et al, 1999), pointing to a need to better
understand the response of human cells and IFNc-mediated
responses to these pathogens.
Both pathogens can induce cell death in the infected cell, which
may promote the spread of infection within the host (Coburn et al,
2007; Krishnamurthy et al, 2017). Tg-induced host-cell death can
vary depending on the host species and IFNc-priming; mechanisms
including pyroptosis and inhibition of apoptosis have been reported
in Tg-infected naı¨ve rodent and human cells. However, the response
of human IFNc-primed macrophages to Tg remains unclear. STm
activates the NLRC4 and NLRP3 inflammasomes in mouse and
human macrophages (Broz et al, 2010; Man et al, 2014; Kortmann
et al, 2015; Reyes Ruiz et al, 2017). Further, IFNc-priming of human
macrophages enhances STm-induced inflammasome activation
(Shenoy et al, 2012; Meunier et al, 2014; Santos et al, 2018).
Whether other GBPs contribute to inflammasome responses to STm
or Tg remains to be determined.
In this study, we systematically studied the roles of human GBPs
in primary monocyte-derived macrophages (MDMs) and PMA-
differentiated THP-1 cells infected with Tg and STm. Notably, Tg
infection in macrophages caused GBP1-dependent apoptosis and
STm infection led to GBP1-dependent increase of pyroptosis. Our
studies uncover a gatekeeping role for human GBP1 and expand the
role of human GBPs in regulating other forms of cell death during
natural infection by microbial pathogens.
Results
GBP1 is an essential mediator of macrophage cell death during
Toxoplasma infection
We investigated the impact of IFNc-priming on host cell death in
PMA-differentiated human THP-1 macrophage-like cells upon
infection with type I (RH) and type II (Pru) Tg, which differ in their
virulence effector repertoire (Saeij et al, 2005). We found that 24 h
post-infection with both Tg strains IFNc-primed macrophages
underwent enhanced cell death, as measured by lactate dehydroge-
nase (LDH) and XTT dye assays (Fig 1A). We hypothesized that
similar to their role in murine cells, GBPs could be involved in
IFNc-enhanced macrophage death. Primary MDMs and THP-1 cells
treated with IFNc express GBP1-5 but not GBP6 or 7 (Fig EV1A),
and both macrophage types also express low, but detectable, levels
of GBP1 in the absence of IFNc stimulation (Fig EV1B). We silenced
individual GBP1–5 by siRNA transfection (Fig EV1C) and quantified
type I and type II Tg infection-induced cell death (Fig 1B). Silencing
of GBP1, but not other family members, abrogated
Tg-induced cell death suggesting an essential role for GBP1 in this
process. GBP1 silencing in primary MDMs also abrogated
Tg-induced cell death further validating its role in human macro-
phages (Fig 1C and Appendix Fig S1A).
GBP1-knockout THP-1 (DGBP1) cells created with CRISPR/Cas9
(Fig EV1D), also failed to undergo cell death upon Tg infection and
provided an independent verification of siRNA experiments
(Fig 1D). THP-1 DGBP1 cells were extensively characterized, and
GBP2-5 expression and sequences in THP-1 DGBP1 were similar to
wild-type THP-1 cells (Fig EV1D–G). Genetic complementation of
THP-1 DGBP1 cells was achieved using a Doxycycline (Dox)-
inducible expression system which mimicked IFNc-induced expres-
sion of GBP1 (Fig EV2A–C). GBP1 protein abundance remained high
over a 24-h period with a protein half-life of 6.3 h, which permitted
Dox pre-treatment and removal during the course of experiments
(Fig EV2D). Indeed, re-expression of GBP1 (THP-1 ΔGBP1 + Tet-
GBP1 cells) restored cell death in response to Tg infection, which
provided additional support for siRNA and CRISPR/Cas9-based
experiments and underscored the role of GBP1 in cell death
(Fig 1D). Real-time propidium iodide (PI) uptake assays, measuring
membrane damage linked to cell death, revealed the kinetics of Tg-
induced cell death (Fig 1E). These assays confirmed the require-
ment for IFNc-priming and the initiation of membrane damage
~ 6 h post-Tg infection (Fig 1E). Similarly, Dox-induced expression
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of GBP1 was necessary for PI uptake in IFNc-primed THP-1
DGBP1 + Tet-GBP1 cells (Fig 1E).
We next sought to determine the molecular determinants of GBP1
involved in cell death and tested this via mutational analyses. We
employed the following GBP1 mutants: K51A lacking GTPase
activity, RK227/228EE with constitutive homodimerization (Vo¨pel
et al, 2010), K382R lacking a ubiquitination site, and C589A and
D589–592 lacking the isoprenylation residue or the CaaX box, respec-
tively (Vo¨pel et al, 2010; Shydlovskyi et al, 2017; Fig EV2E and F).
Notably, GBP1 variants with loss of GTPase activity (K51A) or
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Figure 1. GBP1, its GTPase activity, and isoprenylation are required for IFNc-enhanced cell death upon Toxoplasma infection.
A IFNc enhances macrophage host cell death after type I (RH) and type II (Pru) Toxoplasma gondii (Tg) infection. Graphs show cell death as measured by LDH release
assay (left) and viability measured by XTT assay (right) in untreated or IFNc-primed THP-1 cells infected with type I or type II Tg for 24 h.
B LDH release assays from THP-1 cells left untreated or primed with IFNc, transfected with siRNA against indicated GBPs or non-targeting control (CTRL), and infected
with indicated strains of Tg for 24 h.
C LDH release assay from primary monocyte-derived macrophages (MDM) left untreated or treated with IFNc, transfected with siRNA against GBP1 or non-targeting
control (CTRL), and infected with indicated strain of Tg for 24 h. Mean  SEM of n = 4 donors shown.
D LDH release assay from indicated wild-type, GBP1-knockout (DGBP1), or GBP1-reconstituted (DGBP1 + Tet-GBP1) cells infected with type I or type II Tg for 24 h. Cells
were untreated or treated with IFNc or additionally treated with Doxycycline (Dox) as indicated.
E Real-time propidium iodide (PI) uptake assay from the indicated THP-1 cells infected with type I or type II Tg, and untreated or treated with IFNc and/or Dox as
labeled. AU, arbitrary units.
F LDH release assay from wild-type THP-1 or DGBP1 cells stably reconstituted with Dox-inducible expression plasmids of the indicated mutants of GBP1. Cells were
pre-treated with IFNc and Dox and infected with either type I or type II Tg for 24 h.
Data information: Graphs in (A, B and D-F) show mean  SEM from n = 3 independent experiments. *P ≤ 0.05; **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001 for indicated
comparisons in (A–D) from two-way ANOVA or comparison between THP-1 WT and other genotypes by one-way ANOVA in (F) following adjustment for multiple
comparisons; ns, not significant.
ª 2019 The Authors The EMBO Journal 38: e100926 | 2019 3 of 19
Daniel Fisch et al The EMBO Journal
isoprenylation (C589A or D589–592) were unable to restore Tg-
induced cell death in DGBP1 cells (Fig 1F). Taken together, these
experiments established that human GBP1 was required for macro-
phage cell death in response to infection by type I or type II Tg and its
GTPase activity and isoprenylation were essential for this function.
Toxoplasma induces GBP1-, AIM2-, ASC-, and caspase-8-
dependent apoptosis in macrophages
Tg-induced cell death in human macrophages is poorly character-
ized. To investigate mechanisms of cell death, we used pan-caspase
inhibitors during infection and found that they completely inhibited
cell death (Fig EV3A). As GBPs are known to be involved in pyrop-
tosis, and Tg infection of rodent macrophages causes pyroptosis via
NLRP1 and NLRP3 (Cirelli et al, 2014; Ewald et al, 2014; Gorfu
et al, 2014), we reasoned that human macrophages infected with Tg
might also undergo pyroptosis. However, unexpectedly, cell death
in IFNc-primed THP-1 DCASP1 or DCASP4 CRISPR/Cas9-knockout
cells, or THP-1 with stable silencing of gasdermin D (GSDMD;
GSDMDmiR cells), the pore forming protein responsible for pyropto-
sis, was comparable to that in wild-type THP-1 cells (Fig 2A). Matu-
ration of caspase-1 and IL-1b or IL-18 into their active forms could
not be detected in Tg-infected macrophages irrespective of the
absence or presence of GBP1 (Fig EV3B and C). These findings
together ruled out pyroptotic cell death 18 h after Tg infection. In
contrast, THP-1 DASC cells were resistant to Tg-induced cell death
(Fig 2A). As ASC has previously been implicated in apoptosis, we
measured apoptosis using an Annexin V (AnnV)-Glo luminescence
assay and performed immunoblots for caspases and the apoptotic
substrate PARP. Indeed, IFNc-primed MDMs infected with Tg
displayed marked apoptosis within 3 h post-infection, which
preceded PI uptake induced by post-apoptotic necrotic membrane
damage (Silva, 2010; Fig 2B). Further, primary MDMs transfected
with GBP1 siRNA failed to show increased AnnV-Glo upon Tg infec-
tion (Fig 2B and Appendix Fig S1A). Similarly, wild-type, but not
THP-1 DGBP1 cells, showed increased AnnV-Glo in response to Tg
infection (Fig EV3D). Flow cytometry-based quantification of apop-
tosis using AnnV staining provided concordant results showing
elevated apoptosis upon IFNc-priming and lack of apoptosis in
DGBP1 cells (Fig EV3E). We used TNFa plus cycloheximide (CHX)
or staurosporine as positive controls to induce apoptosis, which not
only verified our assays, but also indicated that wild-type and THP-
1 DGBP1 cells do not have broad defects in extrinsic or intrinsic
apoptosis (Fig EV3F). These findings indicated that GBP1 was
specifically involved in microbe-dependent apoptosis. Immunoblots
from MDMs and THP-1 cells infected with type I and type II Tg
revealed the presence of cleaved caspase-3, caspase-6, caspase-7
and caspase-8, and cleaved PARP (Figs 2C and EV3G). Live time-
lapse imaging showed a temporal increase of caspase-3/7 activity,
shrinking of the cells, and the presence of apoptotic bodies upon
infection with type I or type II Tg (Fig 2D and E). The presence of
nuclear fragmentation and condensation of chromatin further
supported apoptotic cell death during Tg infection (Fig EV3H).
These experiments unequivocally established that Tg-infected
human macrophages undergo apoptosis in a GBP1- and ASC-depen-
dent manner.
We next asked which caspase mediated apoptosis in Tg-infected
macrophages? We therefore performed a family-wide RNAi screen
against caspases to assess their involvement. Silencing of caspase-8
or caspase-10 in THP-1 cells reduced Tg-induced apoptosis (Fig 2F
and Appendix Fig S1B). Although caspase-8 was also required for
Tg-induced apoptosis in primary MDMs, caspase-10, which is a
human-specific caspase, was dispensable (Fig 2G and Appendix Fig
S1A). Silencing of caspase-8 also inhibited cell death in Tg-infected
THP-1 ΔCASP1 and ΔCASP4, which ruled out a role for these
caspases in the process (Fig EV4A). We therefore concluded that
caspase-8 was essential for apoptosis upon Tg infection. To investi-
gate the potential role of an NLR/ALR that could detect Tg infection
and induce apoptosis via the adaptor ASC, we used RNAi against
common NLRs and AIM2. RNAi experiments in THP-1 cells revealed
that silencing of AIM2, but not NLRP1, NLRP3, or NLRC4, abolished
apoptosis (Fig 3A and Appendix Fig S1B). AIM2 silencing also led to
diminished apoptosis in Tg-infected primary MDMs (Fig 3B and
Appendix Fig S1A). We therefore concluded that Tg-infected human
macrophages undergo GBP1-, AIM2-, ASC-, and CASP8-driven apop-
tosis.
AIM2 forms oligomeric inflammasome “specks” for caspase-1
activation. Indeed, ~ 20% of Tg-infected macrophages had ASC
specks; however, 95% of these also recruited caspase-8 (Fig 3C).
Like Tg-induced apoptosis, the formation of ASC–caspase-8 specks
was dependent on IFNc treatment and independent of caspase-1
(Fig 3C). Next, we wanted to investigate why AIM2 and ASC did
not activate caspase-1 as is typical of AIM2 activation. Immunoblots
of Tg-infected MDMs (Fig 3D) and THP-1 (Fig EV3I) cells revealed
loss of caspase-1, NLRP1, NLRP3, NLRC4 proteins over a time
course of 6 h. In agreement with reduced NLRP3 abundance, Tg-
infected cells responded poorly to the NLRP3 inflammasome-acti-
vating toxin nigericin (Fig EV4B). Importantly, the abundance of
AIM2, whose expression was upregulated by IFNc, was unchanged
during the course of Tg infection. These results also implied that
without IFNc-priming, because of the absence of AIM2 expression,
GBP1 expression alone would not be sufficient for cell death. We
tested this experimentally by treating THP-1 DGBP1 + Tet-GBP1
cells with Dox to induce GBP1 expression and infected them with
Tg. Indeed, heterologous GBP1 expression without IFNc-priming did
not restore apoptosis in THP-1 DGBP1 + Tet-GBP1 cells (Fig EV4C).
In conclusion, these results showed that GBP1 mediated atypical
apoptosis via AIM2-ASC-caspase-8 in Tg-infected human macro-
phages.
GBP1 is recruited to pathogen-containing vacuoles in a GTPase
activity and isoprenylation-dependent manner
Whether human GBP1 targets microbial vacuoles in macrophages is
not known. Murine Gbps in general and human GBPs in some cell
lines are recruited to bacterial and Tg vacuoles (Coers, 2017; Man
et al, 2017; Saeij & Frickel, 2017; Santos & Broz, 2018). As we iden-
tified atypical apoptosis via GBP1 and AIM2, we asked whether
GBP1 was recruited to Tg parasitophorous vacuoles (PVs) and
whether this was required for apoptosis. Endogenous GBP1 in
MDMs was recruited to Tg PVs in an IFNc-dependent manner
(Fig 4A and B). Similarly, Dox-inducible expression of mCherry
(mCH)-tagged GBP1 in THP-1 DGBP1 targeted to the PV upon IFNc
treatment (Fig 4A and B). We also tested whether the mutants
GBP1K51A, GBP1C589A, and GBP1D589–592, which did not support
apoptosis, targeted to PVs. All three mutants failed to decorate Tg
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Figure 2. GBP1 promotes ASC- and CASP8-dependent atypical apoptosis in Toxoplasma-infected human macrophages.
A Propidium iodide (PI) uptake in wild-type THP-1 or DCASP1, DCASP4, DASC cells, or THP-1 stably expressing GSDMD-targeting miRNA (GSDMDmiR) infected with the
indicated strains of Toxoplasma gondii (Tg) for 24 h. Cells were untreated or treated with IFNc as indicated. Mean area under the curve (AUC)  SEM from n = 3
experiments are shown. ns, not significant, from two-way ANOVA following adjustment for multiple comparisons.
B Real-time apoptosis assay (Annexin V (AnnV)-Glo luminescence) from IFNc-primed primary human MDMs transfected with non-targeting control (siCTRL; left) or
GBP1 siRNA (siGBP1; right) and left uninfected or infected with type I or type II Tg. Depicted is the mean  SEM of n = 4 donors. AU, arbitrary units.
C Immunoblots from primary MDMs infected with the indicated Tg strains for 12 h. Cells were untreated or pre-treated with IFNc before infection. Treatment with
TNFa and cycloheximide (CHX) served as positive control for apoptosis. Images are representative of n = 4 biologically independent experiments.
D, E Live time-lapse imaging to visualize apoptotic cell death and measure caspase-3/7 activities using a fluorescent caspase substrate. THP-1 WT were primed with
IFNc or left untreated and infected with either type I or type II Tg. Plot in (D) shows cumulative caspase-3/7 activity from an 18-h time course (mean  SEM from
n = 3 independent experiments). Representative phase-contrast images overlaid with fluorescence signal for caspase-3/7 activity (green) images are shown in (E)
from IFNc-primed THP-1 cells infected with type I Tg captured at indicated times post-infection. Scale bar 20 lm.
F AnnV-Glo assay from IFNc-primed THP-1 transfected with siRNA against the indicated human caspases and infected with type I or type II Tg. Area under the curve
(AUC) from a real-time AnnV-Glo luminescence assays similar to those in (B) is plotted as mean  SEM from n = 3 independent experiments. *P ≤ 0.05,
***P ≤ 0.001, ****P ≤ 0.0001 from two-way ANOVA for indicated comparisons following adjustment for multiple comparisons; ns, not significant.
G AnnV-Glo assay from IFNc-primed primary human MDMs transfected with siRNA against CASP8, CASP10, and non-targeting control (CTRL) and infected with type I
or type II Tg. Area under the curve (AUC) from real-time assays similar to those in (B) are plotted from n = 4 independent experiments. Matched shapes and color
of symbols indicate donors. ****P ≤ 0.0001 from two-way ANOVA following adjustment for multiple comparisons; ns, not significant.
Source data are available online for this figure.
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PVs, thus correlating with their inability to promote apoptosis
(Fig 4A and B). Notably, we did not observe cell death in IFNc-
treated A549 cells infected with Tg (Fig EV4D). We previously
showed that in A549 cells, GBP1 does not traffic to Tg vacuoles but
is required for restricting Tg replication (Johnston et al, 2016). This
indicated that even though cell death requires GBP1-targeting of
PVs, growth restriction is independent of this process. We therefore
propose that PV targeting is required for GBP1-dependent apoptosis
during Tg infection.
GBP1 targets Salmonella-containing vacuoles and mediates
caspase-4-dependent pyroptosis
To better understand common determinants of GBP1 in influencing
host cell death responses to infection, we investigated its role during
STm infection. STm infection causes inflammasome-driven
pyroptosis in macrophages (Franchi et al, 2006; Miao et al, 2006;
Broz et al, 2010). In agreement with previous studies (Shenoy et al,
2012), IFNc-priming of THP-1 cells enhanced pyroptosis and IL-1b
release by ~ 1.5–2 fold after infection by STm at various bacterial
MOIs (Figs 5A and EV4E–G). Expression of GFP by STm did not
affect pyroptosis (Fig EV4E) ruling out non-specific effects of GFP
and allowed us to use this strain in our studies which also included
immunofluorescence microscopy. Like THP-1 cells, IFNc-priming of
primary MDMs also enhanced STm-induced IL-1b release and
pyroptosis (Fig EV4F and G). We tested the involvement of GBP1 in
these processes by RNAi in primary MDMs (Appendix Fig S1A) and
infection of THP-1 DGBP1 cells. In all cases, loss of GBP1 expression
abolished IFNc-mediated enhancement of pyroptosis and reduced it
to levels seen without IFNc-priming (Fig 5B). Together with our
results on Tg infection, these findings pointed toward a broader role
for GBP1 in host cell death during microbial infections.
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Figure 3. Toxoplasma-infected human macrophages die through AIM2-dependent atypical apoptosis.
A AnnV-Glo assay from IFNc-primed THP-1 transfected with siRNA against the indicated human NLR/ALR sensors and infected with type I or type II Toxoplasma gondii
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C Representative images (top) from IFNc-primed THP-1 WT infected with type I Tg for 8 h and stained for ASC and active caspase-8. Blue, Nuclei; Red, ASC; Green,
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Source data are available online for this figure.
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Mechanistically, unlike Tg, STm-induced cell death was abol-
ished by GSDMD silencing in primary MDMs and THP-1 cells
(Figs 5C and EV4H, and Appendix Fig S1A and B), which estab-
lished that STm-infected naı¨ve and IFNc-primed macrophages
undergo pyroptotic cell death. Importantly, in naı¨ve cells, silencing
of caspase-1 or GSDMD reduced STm-induced cell death by ~ 60%,
whereas silencing of caspase-4 had no effect (Fig 5C), which indi-
cated that unprimed macrophages infected with STm underwent
solely caspase-1-dependent pyroptosis. In contrast, in IFNc-primed
THP-1 and primary MDMs, only the combined silencing of caspase-
1 and caspase-4 could completely block STm-induced cell death,
which pointed to the involvement of both caspases under these
conditions (Figs 5C and EV4I, and Appendix Fig S1A and B). During
these experiments, we observed that in IFNc-primed cells, silencing
of either caspase-1 or caspase-4 reduced pyroptosis to levels seen in
naı¨ve cells (Fig 5C). We therefore reasoned that IFNc-induced GBP1
might promote the detection of STm by the noncanonical caspase-4–
caspase-1 pathway and enhanced GSDMD processing by both
caspases. The existence of a GBP1/caspase-4-dependent pathway
was independently supported by experiments in IFNc-primed THP-1
DCASP1 cells which underwent enhanced STm-induced cell death in
response to IFNc-priming which was abolished upon GBP1 silencing
(Fig 5D and Appendix Fig S1B). These findings together indicated
that in IFNc-primed macrophages, STm infection engaged both
caspase-1 and caspase-4 and this required GBP1 (schematic in
Fig 5D).
We next asked whether GBP1 GTPase activity and isoprenyla-
tion contributed to pyroptosis. Indeed, THP-1 DGBP1 cells
expressing GBP1K51A, GBP1C589A, or GBP1D589–592 did not undergo
STm-induced pyroptosis, whereas no such defects were observed
in cells expressing GPB1RK227/228EE or GBP1K382R (Fig 5E). Further-
more, endogenous GBP1 translocated to STm-containing vacuoles
(SCV) in MDMs (Fig 5 and G). GBP1 expressed in basal levels in
MDMs (Fig EV1B) can traffic to SCVs. However, IFNc-priming,
which increased the abundance of GBP1 protein (Fig EV1B),
increased the proportion of decorated SCVs by 2-fold (Fig 5G)
and also the amount of GBP1 on individual SCVs (Fig 5H). mCH-
GBP1, but not GTPase-dead or isoprenylation-deficient variants,
recruited to SCVs in THP-1 DGBP1 cells (Fig 5F and G). This
suggested that targeting of microbial vacuoles and the same
molecular functions of GBP1 were required to mediate apoptosis
during Tg infection and pyroptosis during STm infection. Impor-
tantly, GBP1 did not affect nigericin-induced NLRP3-dependent
pyroptosis (Fig EV4J). This indicated that, like in the context of
apoptosis, the role of GBP1 was restricted to regulating infection-
induced cell death.
We asked whether GBP1 promoted caspase-4 trafficking to SCVs
and addressed this using THP-1 ΔGBP1 + Tet-mCH-GBP1 cells stably
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transduced with catalytically inactive YFP-caspase-4C258S
(Fig EV4K); stable expression of YFP-caspase-4 led to toxicity. YFP-
caspase-4C258S translocation could be detected on 37% of SCVs
within 2 h of infection in Dox- and IFNc-primed cells (Fig 5I and J).
Remarkably, caspase-4 recruitment was completely absent in cells
lacking GBP1 (Fig 5J). Moreover, YFP-caspase-4C258S was only
recruited to STm that was also decorated with GBP1 (Fig 5J), which
resulted in a high Pearson’s correlation coefficient for colocalization
of GBP1 and caspase-4 on GBP1/caspase-4 double-positive STm
(0.76  0.08, n = 529 SCVs). Taken together, we concluded that in
IFNc-primed cells, GBP1 not only traffics to STm, but also promotes
the recruitment and activation of caspase-4.
GBP1 can be bypassed by direct delivery of Toxoplasma lysate or
bacterial LPS into the cytosol
Our results showed that GBP1 recruitment to PVs and SCVs corre-
lated with its ability to promote pathogen-dependent cell death.
Based on work on murine Gbps (Meunier et al, 2014, 2015; Man
et al, 2015), we hypothesized that GBP1 contributed to the release
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of microbial ligands for detection by AIM2 or caspase-4 in the
cytosol of human macrophages (Liu et al, 2018). To obtain experi-
mental support for this, we asked whether GBP1 could be bypassed
by transfecting cells with soluble Tg antigen (STAg) or LPS. Indeed,
STAg transfection led to IFNc-dependent cell death as measured by
AnnV-Glo in MDMs and THP-1 cells and pointed toward the
requirement of an IFNc-induced factor for sensing STAg ligands
(Fig EV5A and B). As levels of caspase-1 were reduced upon Tg
infection, we transfected STAg in DCASP1 cells to mimic Tg infec-
tion. Indeed, like natural Tg infection, STAg transfection triggered
IFNc-dependent apoptosis in DCASP1 cells (Fig 6A). To identify
which component of STAg was required for apoptosis, we treated
STAg with DNase, RNase, trypsin, or a mix of deglycosylation
enzymes prior to transfection. DNase-treated STAg failed to induce
apoptosis in DCASP1 cells and established an essential role of Tg
DNA in this process (Fig 6B). We further verified this by immuno-
blots and AnnV-Glo assays to detect apoptosis following STAg
transfection of DCASP1 cells silenced for the expression of AIM2,
ASC, CASP8, or GBP1. These experiments revealed that STAg
induced GBP1-independent and AIM2-, ASC-, CASP8-dependent
activation of the apoptosis cascade (Fig 6C and D). Taken together,
these experiments reconstituted Tg-induced apoptosis in DCASP1
cells and pointed to the detection of Tg DNA in the cytosol by
AIM2. Furthermore, loss of caspase-1 protein during Tg infection
contributed to the switch in AIM2-dependent pyroptosis
to apoptosis.
We performed similar experiments by transfecting LPS to assess
the role of GBP1 in promoting caspase-4 activation. LPS transfection
of MDMs (Fig 6E) and THP-1 (Fig EV5C) led to GBP1-independent
pyroptosis which was in contrast to the role of GBP1 during natural
infection with STm. As a control, we verified that IL-1b production
by LPS transfection was reduced by GBP5 silencing as has been
described before (Shenoy et al, 2012; Santos et al, 2018; Fig EV5D).
Altogether, our results showed that GBP1 acted as a gatekeeper and
promoted the release of or access to microbial ligands for cytosolic
receptors such as AIM2 and caspase-4 which trigger pathogen-
specific cell death pathways.
Discussion
Here, we report that human GBP1 acts as an upstream regulator of
diverse forms of cell death in macrophages and promotes the activa-
tion of microbe-specific downstream pathways. The access to or
release of microbial ligands in infected macrophages required GBP1,
which therefore acts a gatekeeper of microbe-induced cell death.
GBP1 joins GBP2 and GBP5 in regulating human macrophage pyrop-
tosis, but uniquely also regulates the induction of apoptosis. Our
results highlight the contribution of IFNc priming, the host species,
and microbial pathogen to macrophage cell death. For instance, in
naı¨ve cells, Tg induces necrosis in mouse embryonic fibroblasts
(Zhao et al, 2009), pyroptosis in rat and murine macrophages
(Cavailles et al, 2014; Cirelli et al, 2014; Ewald et al, 2014; Gorfu
et al, 2014), and pyroptosis in human monocytes (Witola et al,
2011; Gov et al, 2017). In contrast, Tg infection of IFNc-stimulated
human foreskin fibroblasts causes an unspecified form of cell death
(Gov et al, 2013; Niedelman et al, 2013). We also found that during
STm infection, IFNc enhanced macrophage pyroptosis in a GBP1-
dependent manner. Importantly, both pathogens relied on similar
molecular determinants of GBP1 to promote host cell death.
GBP1, GBP2, and GBP5 have C-terminal CaaX motifs that
undergo isoprenylation. GBP1 also undergoes GTP-dependent
oligomerization (Daumke & Praefcke, 2016). We showed that GBP1
GTPase activity and lipidation are essential for its role in targeting of
microbial vacuoles and mediating host-cell death. These findings
ascribe additional biological relevance to GBP1 lipidation as demon-
strated from in vitro experiments with unilamellar vesicles and asso-
ciation with phagosomes (Shydlovskyi et al, 2017) and STm in HeLa
cells (Bradfield, 2016). A similar role for lipidation of GBP5 for its
recruitment to LPS OMVs and mouse Gbp1/2 for trafficking to
◀ Figure 5. GBP1 targets Salmonella vacuoles and mediates caspase-4-dependent pyroptosis.A LDH release assay from the indicated THP-1 cells untreated or treated with IFNc and infected with Salmonella Typhimurium (STm) WT or a SPI-1 mutant DinvA for
4 h at indicated multiplicities of infection (MOI). Mean  SEM of n = 3 experiments are shown.
B Propidium iodide (PI) uptake assay from IFNc-primed primary MDMs transfected with non-targeting control siRNA (CTRL) or siRNA against GBP1 (left) or indicated
THP-1 cells (right) infected with STm-GFP for 4 h. Area under the curve (AUC) from real-time assay plotted as mean  SEM from n = 3 independent experiments.
C PI uptake assay from IFNc-primed primary MDMs transfected with indicated siRNA or non-targeting control (CTRL) and infected with STm-GFP for 4 h. Area under
the curve (AUC) from real-time assay plotted as mean  SEM from n = 4 independent experiments.
D PI uptake assay from IFNc-primed or untreated THP-1 DCASP1 cells transfected with the indicated siRNA and infected with STm-GFP for 4 h. Area under the curve
(AUC) from real-time assay plotted as mean  SEM from n = 3 independent experiments. Schematic on right shows overview of the pathway leading to caspase-1
and caspase-4 activation.
E LDH release assay from the indicated THP-1 cells treated with IFNc and Dox and infected with STm-GFP for 4 h. Shown is the mean  SEM of n = 3 experiments.
F, G Representative images (F) and quantification (G) from IFNc-primed THP-1 DGBP1 cells stably reconstituted with Tet-mCH-GBP1, mCH-GBP1K51A, mCH-GBP1C589A, or
mCH-GBP1D589–592 variants or primary MDMs stained for endogenous GBP1. Cells were infected with STm-GFP for 2 h. Blue, Nuclei; Gray, STm; Red, mCH-GBP1; or
Magenta, GBP1. Scale bar, 5 lm. Graph in (G) shows percentage of STm vacuoles targeted by GBP1.
H Quantification of GBP1 recruitment to STm-GFP-containing vacuoles (SCV) in MDMs pre-treated with IFNc or left untreated (UT). Mean  95% CI of GBP1
fluorescence intensity measured on the indicated number (n) of SCVs for each condition from three independent experiments is shown. ****P < 0.0001 by nested
t-test.
I Representative images from THP-1 DGBP1 + Tet-mCH-GBP1 cells stably expressing YFP-CASP4C258S. Cells were infected with STm for 2 h. Blue, Nuclei & STm
(Hoechst dye); Red, mCH-GBP1; Green, YFP-CASP4C258S. Scale bar, 5 lm.
J Quantification of THP-1 DGBP1 + Tet-mCH-GBP1 cells stably expressing YFP-CASP4C258S and infected with STm for 2 h. Graph shows percentage of STm vacuoles
targeted by GBP1, CASP4, or both from n = 3 experiments. n.d. not detected.
Data information: ***P ≤ 0.001, ****P ≤ 0.0001 for indicated comparisons by two-way ANOVA in (B–D, G), comparison between untreated and IFNc-treated in (A) or
THP-1 WT, and other genotypes in (E) by one-way ANOVA following adjustment for multiple comparisons; ns, not significant.
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microbial vacuoles has been identified previously (Finethy et al,
2017; Lindenberg et al, 2017; Santos et al, 2018). The correlation of
microbe-targeting and cell death in our studies mirrored similar find-
ings on mouse and human GBPs that target bacteria and restrict their
replication in a GTPase- and isoprenylation-dependent manner (Kim
et al, 2011; Finethy et al, 2015; Li et al, 2017; Piro et al, 2017;
Wandel et al, 2017). Interestingly, the recruitment of GBP1 to Tg
vacuoles is cell-type specific, as it was shown to target PVs in
mesenchymal stem cells (Qin et al, 2017) but not in A549 lung
epithelial cells (Johnston et al, 2016), which correlates with the abil-
ity of GBP1 to induce cell death upon targeting Tg vacuoles. Simi-
larly, murine Gbps do not target Chlamydia muridarum; however,
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Figure 6. Transfection of pathogen-derived ligands bypasses GBP1 in inducing macrophage death.
A Cell death measured using Annexin V (AnnV)-Glo assay of THP-1 DCASP1 cells transfected with non-targeting control (CTRL) or GBP1 siRNA and treated as indicated.
Cells were primed with IFNc, transfected with soluble Tg antigen (STAg) or both, or left untreated (UT). Area under the curve (AUC) from real-time assay plotted as
mean  SEM from n = 3 independent experiments.
B AnnV-Glo assay from naïve or IFNc-primed THP-1 DCASP1 cells transfected with soluble Tg antigen (STAg) that was untreated (UT) or treated as indicated. Area under
the curve (AUC) from real-time assay plotted as mean  SEM from n = 3 independent experiments.
C Immunoblots from IFNc-primed THP-1 DCASP1 or THP-1 DASC cells transfected with non-targeting control (CTRL), GBP1, AIM2, CASP1, or CASP8 siRNA and then
untreated () or transfected with STAg for 12 h. Images are representative of n = 2 independent experiments.
D AnnV-Glo assay from naïve or IFNc-primed THP-1 DCASP1 cells transfected with non-targeting control (CTRL), GBP1, AIM2, CASP1, or CASP8 siRNA and then untreated
(UT) or transfected with STAg as indicated for 18 h. Area under the curve (AUC) from real-time assay plotted as mean  SEM from n = 3 independent experiments.
Schematic on right shows an overview of pathways leading to caspase-8 activation.
E Propidium iodide (PI) uptake assay from MDMs transfected with non-targeting control (CTRL) or GBP1 siRNA and then left untreated (UT), treated with LPS or
transfection reagent (Lipofectamine) only, or transfected with LPS for 4 h. Area under the curve (AUC) from real-time assays plotted as mean  SEM from n = 4
independent experiments. Schematic on right shows an overview of pathways leading to caspase-4 activation.
Data information: *P ≤ 0.05; ****P ≤ 0.0001 from two-way ANOVA following adjustment for multiple comparisons; ns, not significant.
Source data are available online for this figure.
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they are required for pyroptosis (Finethy et al, 2015). The exact
mechanism by which GBPs interact with pathogen vacuoles and lead
to their opening has been subject of previous studies (Yamamoto
et al, 2012). However, no definitive mechanism has been identified.
Our work provides additional evidence that GBP1 membrane inter-
action depends on its lipidation and GTPase activity, and suggest
these properties contribute to vacuole opening. Further studies are
needed to unravel factors that promote the loading of GBP1 onto
microbial vacuoles and how GBPs restrict intracellular pathogens.
Tg induced AIM2-, ASC-, and caspase-8-dependent cell death in
both primary MDMs and THP-1 cells. We found that Tg-infected
macrophages formed ASC specks that contained active caspase-8.
The sustained expression of AIM2 in Tg-infected macrophages and
the loss of NLRP3 and caspase-1 might suppress the newly
described STING-NLRP3-dependent cell death pathway (Gaidt et al,
2017). In this alternative DNA-sensing pathway, STING causes lyso-
somal damage-induced cell death and NLRP3 activation. Indeed,
transfection of Tg DNA in DCASP1 cells triggered AIM2/ASC/
caspase-8-dependent apoptosis, suggesting that loss of caspase-1
alone was sufficient to switch the cell death mechanism. The role of
other cytosolic DNA-sensors in detecting Tg also needs be explored
in the future (Roers et al, 2016). Similar to our findings on reduced
NLRP3 activation in Tg-infected macrophages, Tg can also suppress
NLRP3 in neutrophils (Lima et al, 2018). Rat and mouse NLRP1B
trigger Tg-induced pyroptosis (Cirelli et al, 2014; Ewald et al, 2014;
Gorfu et al, 2014) and human NLRP1 is implicated in the process in
monocytes (Witola et al, 2011; Gov et al, 2017). Murine NLRP1B
activation requires the liberation of its C-terminal caspase-1 activat-
ing region after undergoing self-cleavage and selective proteasomal
degradation of the N-terminal fragment (Chui et al, 2019; Sandstrom
et al, 2019). It is plausible that unknown Tg effectors fail to target
monocyte NLPR1 and caspase-1. We hypothesize that Tg causes the
total depletion of caspase-1, NLRP1, NLRP3, and NLRC4 through
one or more uncharacterized Tg effector proteins in macrophages.
Why the Tg effectors GRA35, 42, and 43, which are involved in
inflammasome activation in rat macrophages (Wang et al, 2018),
fail to do so in human macrophages needs to be addressed in the
future.
STm activates the NAIP-NLRC4 and/or NLRP3 pathways in
mouse (Franchi et al, 2006; Miao et al, 2006; Broz et al, 2010)
and human macrophages (Kortmann et al, 2015; Reyes Ruiz et al,
2017). Our studies pinpoint a role for GBP1 in the enhancement
of pyroptosis by IFNc stimulation, trafficking, and activation of
caspase-4 and confirm a previously described downstream role for
GBP5 (Shenoy et al, 2012). GBPs can contribute to cytokine
processing and/or pyroptosis by assisting in the activation of
inflammasomes (Shenoy et al, 2012; Pilla et al, 2014; Feeley et al,
2017; Lagrange et al, 2018; Santos et al, 2018) or the release of
microbial ligands by promoting microbial/vacuolar lysis (Meunier
et al, 2014, 2015; Man et al, 2015; Balakrishnan et al, 2018; Liu
et al, 2018). Importantly, both GBP1 and caspase-4 target STm,
and caspase-4 targeting was GBP1-dependent. We hypothesize
that GBP1 facilitates the opening of the bacterial vacuole and
serves an essential role in exposing LPS for detection by caspase-
4 (Shi et al, 2014). STm DsifA, which forms unstable vacuoles
and enters the cytosol, is occasionally targeted by caspase-11 in
murine macrophages (Thurston et al, 2016). In contrast, human
caspase-4 can be activated in naı¨ve macrophages infected with
Francisella (Lagrange et al, 2018) or enteropathogenic E. coli
(Goddard et al, 2019), and the absence of a major role for
caspase-4 in naı¨ve macrophages infected with STm needs to be
investigated further in the future.
We found that the role of GBP1 in cell death could be bypassed
by transfecting molecules from Tg or STm, but not during natural
infection, pointing to its role in liberating microbial ligands. Impor-
tantly, we have discovered microbe-specific activation of divergent
host-cell death types downstream of GBPs. On a systemic level,
depletion of macrophages by apoptosis and pyroptosis has advan-
tages for both host and pathogen depending on the point-of-view.
From the pathogen side, depletion of cells that constitute a major
threat works to their advantage. On the host side, depletion of
infected host cells reduces the number of infectious pathogens and
limits the infection to one hot spot as infected macrophages no
longer travel to other sites. Further, apoptosis may trigger a different
adaptive immune response (Campisi et al, 2014), as compared to
the exuberant inflammation triggered by pyroptosis, and contribute
to the clearance of pathogens trapped in apoptotic cells by efferocy-
tosis (Campisi et al, 2014). In summary, we establish that GBP1
targets microbial vacuoles and promotes different host cell death
against diverse infectious agents. Our study expands the under-
standing of how IFNc influences host cells during infection by two
important pathogens.
Materials and Methods
Cells and parasites
THP-1 (TIB-202, ATCC) were maintained in RPMI with GlutaMAX
(Gibco) supplemented with 10% heat-inactivated FBS (Sigma), at
37°C in 5% CO2 atmosphere. THP-1 cells were differentiated with
50 ng/ml phorbol 12-myristate 13-acetate (PMA, P1585, Sigma)
for 3 days and then rested for 2 days by replacing the differentia-
tion medium with complete medium without PMA. Cells were not
used beyond passage 20. HEK293T and human foreskin fibrob-
lasts (HFF) were maintained in DMEM with GlutaMAX (Gibco)
supplemented with 10% FBS at 37°C in 5% CO2 atmosphere.
THP-1 DCASP1, DCASP4, DASC (Schmid-Burgk et al, 2015), and
GSDMDmiR (Eldridge et al, 2017) were cultured as above. An over-
view of all cell lines made/used in this study is provided in
Appendix Table S1.
Tg expressing luciferase/eGFP (RH type I and Prugniaud (Pru)
type II) or expressing tdTomato were maintained in vitro by serial
passage on monolayers of HFF cells, cultured in DMEM with
GlutaMAX supplemented with 10% FBS, at 37°C in 5% CO2. All
cell culture was performed without addition of antibiotics unless
otherwise indicated. Cell lines were routinely tested for myco-
plasma contamination by immunofluorescence, PCR, and agar
test.
Human macrophage isolation and culture
For isolating primary human macrophages, peripheral blood
mononuclear cells were extracted from leukocyte cones from
healthy donors (NHS) via Ficoll (17544202, GE Healthcare) density
gradient centrifugation. CD14+ Monocytes were extracted using
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magnetic microbeads (130-050-201, MACS Miltenyi). Monocytes
were counted and seeded for 1 week in RPMI containing 10%
human AB serum (H4522, Sigma), GlutaMAX (Gibco), penicillin/
streptomycin (Gibco), and 5 ng/ml hGM-CSF (130-093-864,
Miltenyi). The medium was replaced after 2 and 5 days, to replenish
the hGM-CSF.
Cell treatments
Cells were stimulated for 16 h prior to infection in complete
medium at 37°C with addition of 50 IU/ml human IFNc (285-IF,
R&D Systems). Treatments to induce apoptosis were performed with
50 ng/ml TNFa (210-TA, R&D Systems) and 10 lg/ml cyclohex-
imide (CHX, C7698, Sigma) or 0.5 lg/ml staurosporine (S4400,
Sigma). The caspase inhibitor zVAD-fmk (25 lM, 60332, Cell
Signaling Technologies) or qVD (20 lM, ab141421, Abcam) was
used. To chemically induce pyroptosis, cells were either treated with
10 lM nigericin (N1495, Invitrogen) or transfected with 100 ng LPS
Sm (IAX-100-011, Adipogen) per 60,000 cells using Lipofectamine
2000 (11668027, Invitrogen). Induction of GBP1 expression in the
Doxycycline-inducible cells was performed with 200 ng/ml Doxycy-
cline (D9891, Sigma), which is below the LD50 (6.4 lg/ml) of Dox
for Tg (Chang et al, 1990). To entirely block translation for studying
protein stability in time course experiments, the cells were treated
with 50 lg/ml CHX.
Toxoplasma gondii infection
Parasites were routinely grown in HFFs and passaged the day before
infection to obtain parasites with a high viability for infection. Tg
tachyzoites were harvested from HFFs by scraping the cells and
syringe lysing the cells through a 25G needle. Following syringe
lysis, the Tg suspension was cleared of cell debris by centrifugation
at 50 × g for 5 min and the supernatant transferred into a new tube.
Parasites were pelleted by centrifugation at 500 × g for 7 min,
washed with complete medium, centrifuged again, and finally re-
suspended in fresh medium. Viable parasites were counted with
trypan blue and used for infection at a multiplicity of infection
(MOI) of three for most experiments or 1 for immunofluorescence
imaging. Infection was synchronized by centrifugation at 500 × g
for 5 min. Two hours after infection, extracellular parasites were
removed with three washes with warm PBS and then cells cultured
in fresh medium.
Salmonella Typhimurium infection
STm strain SL1344 was transformed with pFVP25.1, which
contains rpsM promoter driving GFPmut3 (Valdivia & Falkow,
1996), maintained under Ampicillin selection (11593027, Gibco),
and grown on LB + Ampicillin agar plates. STm SL1344 WT strain
was maintained under streptomycin (11860038, Gibco) selection
and grown on LB + Streptomycin agar plates. STm SL1344 DinvA
strain (kind gift from Jorge Gala´n, Gala´n et al, 1992) was main-
tained under streptomycin and kanamycin (11815032, Gibco)
selection and grown on LB + Kanamycin agar plates. The day
before infection bacteria from a single colony were inoculated into
9 ml LB and grown overnight at 37°C. The overnight culture was
diluted 1:20 into LB + 300 mM NaCl (746398, Sigma) and grown
with shaking in a closed container until an OD600 of 0.9. Bacteria
were harvested by centrifugation at 1,000 × g for 5 min and
washed with serum-free cell culture medium twice and re-
suspended in 1 ml medium without FCS. Cells were infected with
STm at an MOI of 30, and infections were synchronized by
centrifugation at 750 × g for 10 min. Infected cells were washed
30 min post-infection three times with warm PBS (806552, Sigma)
to remove extracellular bacteria, and fresh medium containing
100 lg/ml gentamicin (15750060, Gibco) was added for 1 h.
Medium was then replaced with medium containing 10 lg/ml
gentamicin and the infection continued for indicated times. Bacte-
rial MOI used for infections were confirmed by plating on LB agar
plates.
AnnV/PI flow cytometry
For flow cytometry, PMA-differentiated 1 × 106 THP-1 cells were
harvested using accutase (A6964, Sigma) and washed twice with
warm PBS and once in AnnV binding buffer (10 mM HEPES pH 7.4,
140 mM NaCl, 2.5 mM CaCl2). Cells were re-suspended in AnnV
binding buffer containing 1:100 AnnV-PacBlue (A35122, Invitrogen)
and stained at 4°C in the dark for 15 min and washed twice with
AnnV binding buffer. Cells were analyzed on a LSR Fortessa (BD
Biosciences), and data were processed using FlowJo version 10.3
(FlowJo, LLC).
Live time-lapse imaging of apoptosis
To measure apoptosis and caspase activity, THP-1 cells were seeded
in an ImageLock 96-well plate (#4379, Essen Biosciences) and dif-
ferentiated as described above. Cells were then primed with 50 IU/
ml IFNc overnight and infected with type I or type II Tg-expressing
tdTomato as previously described. To measure caspase activity,
NucViewTM 488 caspase-3 substrate was added to the medium (RPMI
without phenol red + 10% FCS) to a final concentration of 5 lM.
Following infection, the cell culture plate was placed in an
IncuCyte ZOOM (Essen Biosciences) and phase-contrast and green
fluorescence images recorded every 15 min over a time course of
18 h. Images were analyzed using the IncuCyte ZOOM software
(Essen Biosciences).
LDH and XTT assay
To determine cell viability and cell membrane integrity using XTT
(Cell proliferation kit II, Roche) and LDH assays (Pierce LDH
Cytotoxicity Assay Kit, 88953, Thermo Scientific), 25,000 THP-1
cells were seeded per well in a 96-well plate and differentiated
with PMA. For both assays, cells were treated and infected in
RPMI without FCS and without phenol red (11835, Gibco) to not
interfere with the colorimetric measurements. For LDH assay,
24 h p.i. cell culture supernatant was harvested and cleared by
centrifugation at 2,000 × g for 5 min, and 50 ll was used to
perform LDH assay according to the manufacturer’s instruction
(absorption at 490 and 680 nm for correction). For XTT assay,
the detection reagent was freshly prepared according to the manu-
facturer’s instruction and added 24 h p.i. with Tg. Cells were then
incubated at 37°C for 4 h, and absorption was measured at 475
and 660 nm for correction.
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AnnV glow assay
Apoptosis kinetics were analyzed using the RealTime-GloTM
Annexin V Apoptosis Assay (JA1001, Promega) according to the
manufacturer’s instruction. To do so, 0.06 × 106 cells were seeded
per well of a white, tissue culture-treated 96-well plates, differenti-
ated, pre-treated, and infected as described before. Simultaneously
with infection, detection reagent was added. Luminescence was
measured using a Fluostar Omega plate reader (BMG Labtech).
No-cell, medium-only controls were used for background correc-
tion.
Real-time propidium iodide (PI) uptake assays
To measure live kinetics of necrotic cell death, 0.06 × 106 cells were
seeded per well of a black-wall, clear-bottom 96-well plate (Corning)
and differentiated with PMA, pre-treated, and infected as described
above. Just before the start of the assay, medium was replaced with
RPMI without phenol red and supplemented with 5 lg/ml propid-
ium iodide (PI, P3566, Invitrogen). Then, the plate was sealed with
a clear, adhesive optical plate seal (Applied Biosystems) and placed
in a plate reader (Fluostar Omega, BMG Labtech) pre-heated to
37°C. PI fluorescence was recorded with top optics every 15 min for
times as indicated.
Immunoblotting
For immunoblotting, 0.5 × 106 cells were seeded per well of a 48-
well plate and differentiated with PMA, pre-treated, and infected as
described above. At the end of treatments, cells were washed with
ice-cold PBS and lysed for 5 min on ice in 50 ll RIPA buffer supple-
mented with protease inhibitors (Protease Inhibitor Cocktail set III,
EDTA free, Merck) and phosphatase inhibitors (PhosSTOP, Roche).
Lysates were cleared by centrifugation at full speed for 15 min at
4°C and transferred into a new tube. Cleared lysates (diluted 1:5)
were used for BCA assay (Pierce BCA protein assay kit, 23225,
Thermo Scientific) to determine protein concentration. Samples
(10 lg of total protein) were run on 4–12% Bis-Tris gels (Novex,
Invitrogen) in MOPS running buffer and transferred on Nitrocellu-
lose membranes using iBlot transfer system (Invitrogen). Depending
on the primary antibody used, the membranes were blocked with
either 5% BSA (A2058, Sigma) in TBS-T or 10% dry-milk (M7409,
Sigma) in TBS-T for at least 1 h at room temperature. Incubation
with primary antibodies was performed at 4°C overnight (all anti-
bodies used in this study can be found in Appendix Table S2). To
develop the blots, the membranes were washed with TBS-T, probed
with 1:5,000 diluted secondary antibodies in 5% BSA in TBS-T, and
washed again. Finally, the membranes were incubated for 2 min
with ECL (Immobilon Western, WBKLS0500, Millipore) and lumi-
nescence was recorded on a ChemiDoc MP imaging system
(Bio-Rad).
To perform immunoblots on culture supernatants, cells were
infected/treated in OptiMEM (1105802, Gibco) without serum.
Proteins in the supernatants were precipitated with 4× volume ice
cold acetone (V800023, Sigma) overnight at 20°C, and pelleted by
centrifugation at full speed for 10 min at 4°C. Pellets were air-dried
for 10 min and re-suspended in 40 ll 2× Laemmli loading dye and
used for immunoblotting.
Quantitative RT–PCR (qRT–PCR)
RNA was extracted from 0.25 × 106 cells using Trizol reagent
(15596026, Invitrogen). GlycoBlue (5 lg/ml, AM9516, Invitrogen)
was added during the isopropanol (190764, Sigma) precipitation
step to enhance precipitation. RNA quality was measured on a
Nanodrop 2000 Spectrophotometer (Thermo Scientific). RNA (1 lg)
was reverse transcribed using the high-capacity cDNA synthesis kit
(4368813, Applied Biosystems). qPCR used the PowerUP SYBR
green (A25742, Applied Biosystems) kit, 20 ng cDNA in a 20-ll
reaction, and primers (Appendix Table S3) at 1 lM final concentra-
tion on a QuantStudio 12K Flex Real-Time PCR System (Applied
Biosystems). Primer specificity was ensured by designing primers to
span exon–exon junctions whenever possible, and for each primer
pair, a melt curve was recorded and compared to in silico predicted
melt curve using uMelt (Dwight et al, 2011). Recorded Ct values
were normalized to the recorded Ct of human HPRT1 and data plot-
ted as DCt (Relative expression).
siRNA transfection
Cells were transfected with siRNAs 2 days prior to infection; at the
same time, the THP-1 differentiation medium was replaced with
medium without PMA or MDM differentiation medium was replaced
on day 5 after seeding. All siRNAs were used at a final concentration
of 30 nM. To prepare the transfection mix, a 10× mix was prepared
in OptiMEM containing the appropriate siRNA(s) and TransIT-X2
transfection reagent (MIR 600×, Mirus) in a 1:2 stoichiometry. As
the GBPs exhibit high sequence similarity, we created a custom
transfection panel using three different silencer select siRNAs
(Ambion):
Gene siRNA 1 Conc. siRNA 2 Conc. siRNA 3 Conc. Final Conc.
GBP1 s5620 20 nM s5621 5 nM s5622 5 nM 30 nM
GBP2 s5623 20 nM s5624 5 nM s5625 5 nM 30 nM
GBP3 s5626 10 nM s5627 10 nM s5628 10 nM 30 nM
GBP4 s41805 7.5 nM s41806 15 nM s41807 7.5 nM 30 nM
GBP5 s41808 5 nM s41809 12.5 nM s41810 12.5 nM 30 nM
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The appropriate negative control was SilencerTM Select Negative
Control No. 1 siRNA (#4390843, Ambion).
All other siRNAs used in this study were OnTarget Plus smart
pool siRNAs (Dharmacon):
Gene Cat. number Gene Cat. number
CASP1 L-004401 CASP9 L-003309
CASP2 L-003465 CASP10 L-004402
CASP3 L-004307 NLRP1 L-004423
CASP4 L-004404 NLRP3 L-017367
CASP5 L-004405 NLRC4 L-004396
CASP6 L-004406 AIM2 L-011951
CASP7 L-004407 GSDMD L-016207
CASP8 L-003466 Negative control D-001810
Creation of THP-1 DGBP1
Plasmid construction for generation of GBP1-deficient THP-1 cells
Oligonucleotides used for creation of the cells are listed in
Appendix Table S4. GBP1-deficient cells were generated with the
pX330 plasmid CRISPR/Cas9 system. The insert fragment of GBP1
gRNA1 or GBP1 gRNA2 was generated by annealing oligonucleotides
and cloned into the BbsI site of the cloning vector containing U6
promoter to generate gRNA-expressing plasmids pGBP1_gRNA1 and
pGBP1_gRNA2, respectively. The XhoI and SalI insert from the
pGBP1_gRNA2 vector was cloned in the XhoI site of the
pGBP1_gRNA1 vector to generate pGBP1_gRNA1/2 plasmid. The
KpnI and MluI fragment from pGBP1_gRNA1/2 was cloned into the
KpnI andMluI sites of pEF6-hCas9-Puro vector (Ohshima et al, 2014).
Generation of GBP1-deficient THP-1 cells by CRISPR/Cas9
genome editing
1 × 106 THP-1 cells were electroporated with 10 lg of the pEF6-hCas9-
Puro vector containing target gRNA1/2 using NEPA21 (Nepa Gene).
48 h post-electroporation, 3 lg/ml puromycin was added for 10 days
to select for cells with a stable integration. Cells were plated in limiting
dilution in 96-well plates to isolate single cell clones. To confirm
complete target gene deficiency, the targeted locus was sequenced, and
the GBP1 protein expression analyzed by immunoblotting.
Creation of Dox-inducible GBP1 cell lines
Cloning of the Doxycycline-inducible system
To reduce leaky expression in the absence of Dox and maintain
high responsiveness to Dox, we combined two transactivator
proteins in one control vector: the transcriptional activator rtTA2S-
M2 that induces expression in the presence of Dox and the
silencer tTS that suppresses expression in the absence of Dox.
rtTA2S-M2 was amplified by PCR from pBSKDB-CAG-rtTA2S-M2-
IRES-tTSkid-IRES-Neo [Addgene #62346, a gift from Hiroshi Ochiai
(Ochiai et al, 2015)], tTS from UbC-TRE-mSOD2-tTS-IRES-EGFP
[Addgene #12390, a gift from Zuoshang Xu (Xia et al, 2006)], P2A
and T2A from pSpCas9(BB)-2A-GFP (PX458) [Addgene #48138, a
gift from Feng Zhang (Ran et al, 2013)], and bsr from pHH3-SP-
lox-GFP-lox [a gift from Anthony Holder (Knuepfer et al, 2017)
with 30 bp overlaps to each other using Q5 DNA-polymerase
(M0491, NEB)]. pLSC-5 [Addgene #62889, a gift from Feng Zhang
(Zetsche et al, 2015)] which has an EFsNS promoter was digested
with EcoRI and KpnI to remove the sgRNA cassette and re-ligated
with repair oligonucleotides and then amplified the backbone with
30 bp overlaps to parts of our new insert without the splitCas-9
ORF. A 6-fragment Gibson assembly with home-made Gibson
master mix created the pTet-ctrl plasmid (with rtTA2S-M2-P2A-tTs-
T2A-bsr fusion gene under the control of EFsNS promoter in a
vector backbone suitable for lentiviral transduction into mamma-
lian cells). All oligonucleotide sequences used for cloning can be
found in Appendix Table S4.
To create a response vector, we used pLSC5 without the sgRNA
cassette and replaced the splitCas-9 ORF with a Zeocin resistance
gene (shBle) by Gibson assembly [shBle was amplified from pSpCas9
(BB)-2A-GFP (pX458)] to generate pLSC-5-Zeocin. The tet response
element (TRE) consisting of a minimal CMV promoter downstream of
a heptamerized tet-operator (Gossen & Bujard, 1992) from WT HA-
dynamin 1 pUHD10-3 [Addgene #34688, a gift from Sandra Schmid
(Damke et al, 1995)] and pLSC-5-Zeocin were used for Gibson assem-
bly to generate a plasmid (pLenti-Tet) suitable for lentiviral transduc-
tion into mammalian cells that contains a TRE promoter and the
Zeocin resistance under control of an EFsNS promoter. Finally, a
multiple cloning site was inserted in the BamHI and EcoRI sites
downstream of the TRE to make the vector more versatile.
GBP1 plasmids
To create plasmids that express GBP1 under the control of Dox,
RNA from IFNc-treated THP-1s was extracted and cDNA was
synthesized. The CDS of the GBP1 mRNA was amplified with Q5
polymerase and the amplicon treated with Taq polymerase (M0273,
NEB) to create A overhangs. Subsequently, the amplicon was cloned
into pCR2.1-TOPO TA vector using TOPO TA kit (451641, Invitro-
gen). Next, GBP1 mutants were created by site-directed mutagene-
sis, introducing single point mutations. Using the mutated or WT
GBP1-containing vectors, the ORFs were amplified using oligonu-
cleotides to create overhangs to pLenti-Tet vector. The target vector
itself was digested using BamHI. We then performed Gibson assem-
bly of the digested backbone and the GBP1 ORFs and confirmed
successful cloning by sequencing. To create mCH-tagged versions,
we additionally amplified mCH ORF with overlaps to the backbone
and GBP1 and included it in the Gibson assembly reactions.
Lentiviral transduction of the Dox-inducible system
Lentiviral packaging used HEK293T cells transfected with required
plasmids, pMD2.G (Addgene #12259, a gift from Didier Trono) and
psPAX2 (Addgene #12260, a gift from Didier Trono) using Lipofec-
tamine 2000 in serum-free DMEM. Medium was replaced 12 h post-
transfection with fresh DMEM + 10% FBS to rest the cells. Medium
was replaced again after 12 h with DMEM + 10% FBS containing
5 mM sodium butyrate (B5887, Sigma) to boost virus production and
left for another 12 h. Medium was replaced with RPMI + 10% FBS
and the cells left to produce lentiviral particles for 1 day. Virus-
containing supernatant was filtered through a 0.43-lm syringe filter
and supplemented with 8 lM polybrene (H9268, Sigma). The THP-1
DGBP1 target cells were then re-suspended in 500 ll of the virus-
containing medium and “spinfected” for 30 min at 720 × g before
being placed back in the incubator. One hour p.i. 1 ml complete
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medium was added, and the cells left to rest. This infection procedure
was repeated for a total of three times before selection with 15 lg/ml
Blasticidin S (15205, Sigma). Once untransduced control cells had
died in the selection medium, the newly created THP-1 DGBP1 + Tet
cells were then transduced with the GBP1 ORF-containing response
vectors (pLenti-Tet) following the same procedure and selection was
performed using 200 lg/ml Zeocin (J67140, Alfa Aesar).
Creation of YFP-CASP4-expressing cell lines
Cloning of YFP-CASP4 retroviral vectors
CASP4 and CASP4C258S ORF was amplified by PCR (Pallett et al,
2017) from plasmids kindly gifted by Mitchel Pallett and cloned into
pMX-CMV-YFP [CMV-driven expression of YFP derived from
pEYFPC1 (Clontech; Eldridge et al, 2017) via sequence- and liga-
tion-independent cloning (SLIC)]. CASP4C258S mutation was gener-
ated by cloning two overlapping PCR fragments (by Mitchel Pallett)
and was used as template for PCR to generate plasmid pMX-CMV-
YFP-CASP4C258S.
Retroviral transduction of caspase-4 into THP-1 cells
Caspase-4-encoding plasmids and the packaging plasmids pCMV-
MMLV-pack (Shenoy et al, 2012) and pVSVg were transfected into
HEK293T cells in serum-free DMEM using Lipofectamine 2000 at a
ratio of 5:4:1, to produce retroviral particles for transduction.
Medium was replaced 12 h post-transfection with fresh DMEM
+ 10% FBS to rest the cells. Medium was replaced again after 12 h
with DMEM + 10% FBS containing 5 mM sodium butyrate to boost
virus production and left for another 12 h. Medium was replaced
with RPMI + 10% FBS and the cells left to produce lentiviral particles
for 1 day. Virus-containing supernatant was filtered through a 0.43-
lm syringe filter and supplemented with 8 lM polybrene. The THP-1
DGBP1 + Tet-mCH-GBP1 target cells were then re-suspended in
500 ll of the virus-containing medium and “spinfected” for 30 min at
720 × g before being placed back in the incubator. One hour p.i. 1 ml
complete medium was added, and the cells left to rest. This infection
procedure was repeated for a total of three times before selection
with 1 lg/ml puromycin. Once untransduced control cells had died
in the selection medium, the newly created cells were tested by
immunoblotting and subsequently used for experiments.
IL-1b and IL-18 ELISA
To measure the production and secretion of cytokines by infected
THP-1s, the cell culture supernatant was harvested and cleared by
centrifugation at 2,000 × g for 5 min. The cleared supernatants were
then diluted in the buffer provided with the ELISA kits, and ELISA
was performed according to the manufacturer’s instruction. IL-1b
ELISA kit was from Invitrogen (#88-7261, detection range 2–150 pg/
ml), and IL-18 ELISA was from R&D Systems (#7620, detection
range 12.5–1,000 pg/ml).
Fixed immunofluorescence microscopy
For confocal imaging, 0.25 × 106 THP-1 cells were seeded on gelatin-
coated (G1890, Sigma) coverslips in 24-well plates and differentiated
with PMA. Following treatments and infection, cells were washed
three times with warm PBS prior to fixation to remove any
uninvaded pathogens and then fixed with 4% methanol-free
formaldehyde (28906, Thermo Scientific) for 15 min at room temper-
ature. Following fixation, cells were washed again with PBS and kept
at 4°C overnight to remove any unreacted formaldehyde. Fixed spec-
imens were permeabilized with PermQuench buffer (0.2% (w/v)
BSA and 0.02% (w/v) saponin in PBS) for 30 min at room tempera-
ture and then stained with primary antibodies for 1 h at room
temperature. After three washes with PBS, cells were incubated with
the appropriated secondary antibody and 1 lg/ml Hoechst 33342
(H3570, Invitrogen) diluted in PermQuench buffer for 1 h at room
temperature. Cells were washed with PBS five times and mounted
using 5 ll ProLongTM Gold Antifade Mountant (P36930, Invitrogen).
For imaging of caspase-8 recruitment to ASC specks, FITC-IETD-
fmk (88-7005-42, Invitrogen) was added to the culture medium 1 h
prior to fixation. Cells were then fixed and stained as detailed above.
Specificity of the home-made GBP1-antibody was validated by
staining IFNc-primed THP-1 ΔGBP1 + Tet-GBP1 cells (express all
GBPs but GBP1) that were additionally treated with Doxycycline as
a positive control (Appendix Fig S2).
Specimens were imaged on a Leica SP5-inverted confocal micro-
scope using 100× magnification and analyzed using LAS-AF soft-
ware. Images were further formatted using FIJI software.
Quantification of protein recruitment to pathogen vacuoles and
ASC speck formation
Cells seeded as above were infected with Tg MOI = 1 and fixed 6 h
p.i. or STm-GFP MOI = 30 and fixed 2 h p.i. Nuclei were stained
with Hoechst 33342 and coverslips mounted as described above.
Images were acquired using a Ti-E Nikon microscope equipped with
LED-illumination and an Orca-Flash4 camera using a 60× magnifi-
cation. All intracellular vacuoles of 100 fields of view were automat-
ically counted based on whether they show recruitment of GBP1,
caspase-4, both, or no recruitment using HRMAn high-content
image analysis (Fisch et al, 2019). Further, the analysis pipeline
was used to measure the fluorescence intensity of GBP1 on STm
vacuoles using the radial intensity measurement implemented in
HRMAn. The Pearson’s correlation coefficient for colocalization
analysis was also computed on cropped STm vacuoles, that have
been classified as decorated with both proteins by HRMAn, using
Fiji. The experiment was repeated independently three times.
For quantification of ASC speck formation and caspase-8 recruit-
ment, 100 Tg-infected cells were manually counted per condition
using a Ti-E Nikon microscope equipped with LED-illumination
using a 100× magnification based on whether they contain an ASC
speck and whether caspase-8 was recruited to this speck. The exper-
iment was repeated independently three times.
STAg preparation, pre-digestion, and transfection
STAg was prepared as described previously (Gazzinelli et al, 1991).
In brief, parasites from a confluent T25 flask were lysed by freezing
at 80°C and thawing at 37°C followed by four 20-s rounds of soni-
cation. The resulting homogenate was centrifuged at 590 × g for
10 min, and supernatant collected. To deplete STAg of specific
components, it was pre-treated with either 5 U/rxn of Turbo DNase
(AM2238, Invitrogen) to digest DNA, 10 lg/ml RNase A (EN0531,
Thermo Scientific) to digest remaining RNA, trypsin (90057, Thermo
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Scientific) to digest proteins [protease to protein ratio 1:20 (w/w)],
or with Protein Deglycosylation Mix II (P6044, NEB) to get rid of
any glycosylation overnight. Untreated or pre-treated STAg was then
transfected into THP-1s using Lipofectamine 2000 (1 ll STAg per
well of a 96-well plate).
Data handling and statistics
Graphs were plotted using Prism 8.0.2 (GraphPad Inc.) and presented
as means of N = 3 experiments (with usually three technical repeats
within each experiment) with error bars representing SEM, if not
stated otherwise. Data analysis used one-way ANOVA, two-way
ANOVA, nested t-test, or unpaired Student’s t-test as indicated in the
figure legends. Benjamini, Krieger, and Yekutieli false-discovery rate
(Q = 5%)-based correction for multiple comparisons as implemented
in Prism was used when making more than three comparisons.
Expanded View for this article is available online.
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